Profile
Sector:
HealthcareIndustry:
Medical DevicesCountry:
United StatesIPO:
20 October 2016Website:
http://www.irhythmtech.comNext earnings report:
21 February 2025Last dividends:
N/ANext dividends:
N/APrice
after hours | 82 min agoDividend
Analysts recommendations
Institutional Ownership
Included in screeners
IRTC Latest News
iRhythm Technologies, Inc. (NASDAQ:IRTC ) Q3 2024 Results Conference Call October 30, 2024 4:30 PM ET Company Participants Stephanie Zhadkevich - Director, Investor Relations Quentin Blackford - President and CEO Daniel Wilson - Chief Financial Officer Conference Call Participants Allen Gong - JPMorgan Macauley Kilbane - William Blair Kallum Titchmarsh - Morgan Stanley Marie Thibault - BTIG LLC David Ryman - Goldman Sachs David Rescott - Baird Richard Newitter - Truist William Plovanic - Canaccord Genuity Suraj Kalia - Oppenheimer Operator Hello, everyone, and welcome to iRhythm's Third Quarter 2024 Earnings Call. My name's Lydia, and I'll be your operator today.
IRhythm Technologies (IRTC) came out with a quarterly loss of $1.26 per share versus the Zacks Consensus Estimate of a loss of $0.55. This compares to loss of $0.89 per share a year ago.
Zio AT device, along with the Zio ECG Utilization Software (ZEUS) (K222389), enables the provision of ambulatory Mobile Cardiac Telemetry (MCT) monitoring service for non-critical care patients
SAN FRANCISCO, Oct. 28, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health company focused on creating trusted solutions that detect, predict, and prevent disease, today announced that the results of the Extended Ambulatory ECG Monitoring Enhances Identification of Higher-Risk Ventricular Tachyarrhythmias in Patients with Hypertrophic Cardiomyopathy (EXAMINE-HCM) study have been published in Heart Rhythm Journal . The findings were also presented at the Heart Rhythm Society's annual meeting in 2023, and most recently, at the International HCM Summit 8 in Boston, MA (October 25-28, 2024).
On Monday, the FDA approved iRhythm Technologies, Inc.'s IRTC 510(k) submission related to prior design changes to the Zio AT device via letter to file.
IRTC receives FDA 510(k) clearance for prior design modifications to its Zio AT device, reinforcing its commitment to quality and compliance.
PHILADELPHIA, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating iRhythm Technologies, Inc. (NASDAQ: IRTC) (“iRhythm”) on behalf of the company's long-term shareholders.
IRTC's Zio ECG monitoring system gets approval in Japan, marking a significant step in revolutionizing arrhythmia diagnostics with AI-powered technology.
SAN FRANCISCO, Sept. 11, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, announced today that it has received regulatory approval from the Japanese Pharmaceutical and Medical Device Agency (PMDA) for the Zio® fourteen-day, long-term continuous ECG monitoring system. With regulatory approval in hand, iRhythm intends to work towards a reimbursement decision for the Zio ECG monitoring system with the Japanese Ministry of Health, Labour, and Welfare (MHLW).
IRTC announces initial findings demonstrating the superior real-world performance of the next-generation Zio LTCM Monitor at the HRX 2024 meeting.
- 1(current)
- 2
What type of business is iRhythm Technologies?
iRhythm Technologies, Inc. is a digital company serving the healthcare industry. It is a provider of ECG ambulatory monitoring solutions for patients at risk of arrhythmias - portable Zio service biosensors with cloud data analysis. It is a vertically integrated company headquartered in San Francisco, California. The company was founded on September 14, 2006. The company's flagship product is the Zio service platform, which provides a wide range of capabilities for ambulatory heart monitoring. The platform combines a convenient and unobtrusive biosensor for wearing (up to 14 consecutive days) with powerful patented algorithms that turn data from a million heartbeats into clinically actionable information.
What sector is iRhythm Technologies in?
iRhythm Technologies is in the Healthcare sector
What industry is iRhythm Technologies in?
iRhythm Technologies is in the Medical Devices industry
What country is iRhythm Technologies from?
iRhythm Technologies is headquartered in United States
When did iRhythm Technologies go public?
iRhythm Technologies initial public offering (IPO) was on 20 October 2016
What is iRhythm Technologies website?
https://www.irhythmtech.com
Is iRhythm Technologies in the S&P 500?
No, iRhythm Technologies is not included in the S&P 500 index
Is iRhythm Technologies in the NASDAQ 100?
No, iRhythm Technologies is not included in the NASDAQ 100 index
Is iRhythm Technologies in the Dow Jones?
No, iRhythm Technologies is not included in the Dow Jones index
When was iRhythm Technologies the previous earnings report?
No data
When does iRhythm Technologies earnings report?
The next expected earnings date for iRhythm Technologies is 21 February 2025